SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-159219
Filing Date
2020-06-03
Accepted
2020-06-03 10:12:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d932471d424b5.htm 424B5 673038
2 GRAPHIC g932471arcalogo.jpg GRAPHIC 3400
3 GRAPHIC g932471g0603133918247.jpg GRAPHIC 2922
4 GRAPHIC g932471g0603133919449.jpg GRAPHIC 3871
5 GRAPHIC g932471g0603133921477.jpg GRAPHIC 3073
  Complete submission text file 0001193125-20-159219.txt   693134
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238067 | Film No.: 20939150
SIC: 2835 In Vitro & In Vivo Diagnostic Substances